Ipilimumab/nivolumabColitis and skin toxicity: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1696卷 / 1期

关键词：

D O I：

10.1007/s40278-018-44401-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：213 / 213

相关论文

共 50 条

[41] NivolumabColitis: case report [J].

Reactions Weekly, 2022, 1926 (1) :373-373

[42] Ipilimumab/nivolumabHepatic toxicity: case report [J].

Reactions Weekly, 2022, 1887 (1) :395-395

[43] Ipilimumab/nivolumabHepatic toxicity: case report [J].

Reactions Weekly, 2022, 1908 (1) :303-303

[44] NivolumabColitis: case report [J].

Reactions Weekly, 2025, 2056 (1) :426-426

[45] NivolumabColitis: case report [J].

Reactions Weekly, 2017, 1665 (1) :213-213

[46] Ipilimumab/nivolumabVogt-Koyanagi-Harada disease, duodenitis and skin toxicity: case report [J].

Reactions Weekly, 2019, 1747 (1) :161-161

[47] NivolumabColitis and pancreatitis: case report [J].

Reactions Weekly, 2022, 1913 (1) :353-353

[48] NivolumabColitis and diarrhoea: case report [J].

Reactions Weekly, 2022, 1932 (1) :473-473

[49] Ipilimumab/nivolumabLichenoid skin eruption : case report [J].

Reactions Weekly, 2023, 1963 (1) :301-301

[50] Ipilimumab/nivolumab/nivolumabColitis and lack of efficacy [J].

Reactions Weekly, 2024, 2005 (1) :469-469

← 1 2 3 4 5 →